ECHOPLEV: Thoracic Ultrasound in the Treatment of Pleural Effusion

Sponsor
University Hospital, Toulouse (Other)
Overall Status
Recruiting
CT.gov ID
NCT02505763
Collaborator
(none)
144
1
2
64.7
2.2

Study Details

Study Description

Brief Summary

The main objective of the study is to assess the cost-effectiveness ratio of two management strategies of pleurisy in adults : a strategy by systematic thoracic ultrasound versus a strategy without thoracic ultrasound.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Strategy with thoracic ultrasound
N/A

Detailed Description

Comparison of two management strategies pleural effusions from diagnosis and during the first year of follow up care.

Patients are randomized into two groups, each group receiving a different management strategy.

Both strategies are compared:

Strategy A that involves the systematic use of thoracic ultrasound for the treatment of pleural effusion, treatment and follow up care. It will be possible to have recourse to other tests (such as chest CT) if deemed necessary by the practitioner.

Strategy B, which consists of the usual care pleurisy and thus without use of ultrasound:

gestures are guided either by chest radiograph or by CT chest as necessary in the treatment and monitoring. A systematic radiographic pleural after each gesture is performed.

The management is inspired by the English recommendations currently validated and applied in Anglo-Saxon countries.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
144 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Treatment of Pleural Effusion by Routine Thoracic Ultrasound
Actual Study Start Date :
Jul 10, 2017
Anticipated Primary Completion Date :
Dec 1, 2021
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Strategy with thoracic ultrasound

Use of thoracic ultrasound for the treatment of pleural effusion, treatment and monitoring. Use of other examinations like chest CT if necessary

Procedure: Strategy with thoracic ultrasound
This strategy involves the systematic use of thoracic ultrasound for the treatment of pleural effusion, treatment and follow up care.

No Intervention: Strategy without thoracic ultrasound

Usual care : without thoracic ultrasound Use of chest radiography or chest CT scan if necessary, as for treatment and monitoring. Usual care: without the use of ultrasound Using either chest radiography or TDM if necessary, as for treatment and monitoring.

Outcome Measures

Primary Outcome Measures

  1. The cost-effectiveness ration [1 year]

    Cost estimates will be conducted from the perspective of health insurance. The expenses incurred in the care of patients with pleurisy will be counted in both groups during the follow-up year. The effectiveness will be assessed against the complications of strategy (pneumothorax, respiratory sequelae, surgery, mortality, chest pain sequelae, radiological consequences).

Secondary Outcome Measures

  1. The duration of hospitalization [1 year]

    number of day of hospitalization between the two strategies

Other Outcome Measures

  1. The irradiation rate [1 year]

    calculation of irradiation rate between the two strategies

  2. Number of consultations [1 year]

    The number of consultations between the two strategies

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients hospitalized or seen in consultation with pleural effusion diagnosed clinically or radiologically whatever be its initial management.
Exclusion Criteria:
  • Patient with a neoplasia

Contacts and Locations

Locations

Site City State Country Postal Code
1 NOEL-SAVINA Elise Toulouse Midi Pyrenees France 31059

Sponsors and Collaborators

  • University Hospital, Toulouse

Investigators

  • Principal Investigator: Elise NOEL-SAVINA, MD, University Hospital, Toulouse

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital, Toulouse
ClinicalTrials.gov Identifier:
NCT02505763
Other Study ID Numbers:
  • RC31/14/7418
First Posted:
Jul 22, 2015
Last Update Posted:
Nov 9, 2020
Last Verified:
Nov 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 9, 2020